Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:
Net income	$ 224.2	$ 317.2
(Income) loss from discontinued operations	(2.8)	1.2
Adjustments to reconcile net income to net cash provided by operating activities-
Provision for doubtful accounts	25.0	22.4
Government, class action, and related settlements	(0.8)	(23.3)
Depreciation and amortization	80.2	69.5
Equity in net income of nonconsolidated affiliates	(8.8)	(8.2)
Distributions from nonconsolidated affiliates	9.4	9.6
Stock-based compensation	19.3	19.0
Deferred tax expense (benefit)	81.6	(20.8)
Gain on consolidation of Fairlawn Rehabilitation Hospital	(27.2)	0
Other	13.0	6.0
(Increase) decrease in assets-
Accounts receivable	(48.7)	(26.5)
Other assets	8.9	(4.5)
Increase (decrease) in liabilities-
Accounts payable	3.7	9.9
Other liabilities	(7.6)	(0.7)
Premium received on bond issuance	6.3	0
Net cash used in operating activities of discontinued operations	(1.0)	(1.4)
Total adjustments	153.3	51.0
Net cash provided by operating activities	374.7	369.4
Cash flows from investing activities:
Purchases of property and equipment	(133.9)	(166.8)
Capitalized software costs	(12.6)	(15.6)
Acquisition of business, net of cash acquired	(15.9)	(28.9)
Proceeds from sale of restricted investments	0.3	16.9
Proceeds from sale of Digital Hospital	0	10.8
Purchase of restricted investments	(2.5)	(8.1)
Other	2.3	(5.5)
Net cash used in investing activities	(162.3)	(197.2)
Cash flows from financing activities:
Proceeds from bond issuance	175.0	0
Principal borrowings on notes	0	15.2
Borrowings on revolving credit facility	65.0	147.0
Payments on revolving credit facility	(110.0)	(112.0)
Repurchase of common stock, including fees and expenses	(43.1)	(234.1)
Dividends paid on common stock	(47.4)	0
Dividends paid on convertible perpetual preferred stock	(4.7)	(17.2)
Distributions paid to noncontrolling interests of consolidated affiliates	(39.6)	(34.1)
Other	0.2	(4.8)
Net cash used in financing activities	(4.6)	(240.0)
Increase (decrease) in cash and cash equivalents	207.8	(67.8)
Cash and cash equivalents at beginning of period	64.5	132.8
Cash and cash equivalents at end of period	$ 272.3	$ 65.0